Eko Foundation Analysis Software with Transformers (EFAST) vs Tempus ECG-Low EF

Tool A (EFAST) offers real-time AI analysis during auscultation, integrated with digital stethoscopes, featuring waveform visualization and guided exams. This provides an interactive and immediate user experience during a physical examination. Tool B (Tempus ECG-Low EF) analyzes existing ECG recordings and provides a binary output, focusing on processing pre-recorded data rather than real-time interaction at the point of care.

Tool A (EFAST) is FDA-cleared for detecting structural murmurs (93% sensitivity, 91% specificity) and atrial fibrillation (95% sensitivity, 94% specificity), offering real-time, actionable insights for two distinct and common cardiac conditions. Tool B (Tempus ECG-Low EF) is also FDA-cleared and aids in identifying patients at risk of heart failure by detecting signs of low LVEF from ECGs. While both provide significant clinical value, EFAST's specific, high-performance metrics for two conditions and its real-time application during routine exams give it a slight edge in immediate clinical impact.

Tool A (EFAST) offers a subscription-based model with an Eko+ yearly membership, including a free trial with stethoscope purchase, and transparently states the associated stethoscope technology costs approximately $2.00/day. This provides more insight into its pricing structure. Tool B (Tempus ECG-Low EF) only states 'contact vendor' for pricing, offering no public details on its cost model.

Both tools demonstrate strong enterprise readiness. Tool A (EFAST) is a cloud-based Software as a Medical Device (SaMD), HIPAA compliant, has a BAA, and explicitly mentions EMR integration. Tool B (Tempus ECG-Low EF) is also HIPAA compliant, has a BAA, and is designed to be integrated into healthcare facility workflows. Both are FDA-cleared, indicating a high level of regulatory compliance and suitability for clinical environments.

Tool A (EFAST) leverages an advanced AI model with 'Transformers' for real-time analysis during auscultation, seamlessly integrating with digital stethoscopes to provide immediate, actionable insights at the point of care. This represents a more novel and disruptive application within the physical examination workflow. Tool B (Tempus ECG-Low EF) uses AI to analyze existing 12-lead ECG recordings for LVEF, which, while innovative, is a more established application of AI in cardiology compared to real-time auscultation analysis.

Tool A (EFAST) benefits from Eko Health's comprehensive online Help Center, which includes FAQs, product-specific user manuals (including for EFAST), how-to videos, and multiple contact options such as email, phone, and support tickets. Tool B (Tempus ECG-Low EF) offers customer support via email and phone, but publicly available, specific documentation for ECG-Low EF appears less extensive or centralized compared to Eko's offerings.